Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this study is to investigate the self-reported
impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic
vaginitis due to oestrogen deficiency.